Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML

about

Targeted sequencing of large genomic regions with CATCH-Seq

P2860

Q34428477-381F94E2-EF88-47F7-BA91-7AE0B642EE65

P2860

Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML

Item

http://www.wikidata.org/entity/Q36797201

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Potential of whole-genome sequ ...... nalizing therapy: focus on AML

@en

type

Item

label

Potential of whole-genome sequ ...... nalizing therapy: focus on AML

@en

prefLabel

Potential of whole-genome sequ ...... nalizing therapy: focus on AML

@en

P1476

Potential of whole-genome sequ ...... nalizing therapy: focus on AML

@en

P2093

Boris Pasche

http://www.w3.org/2001/XMLSchema#string

Harry P Erba

http://www.w3.org/2001/XMLSchema#string

Uma Borate

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

DNMT3A Mutations in Acute Myeloid Leukemia

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

P304

1289-1297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.12.116

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Devin Absher

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23176617

http://www.w3.org/2001/XMLSchema#string

P932

3636990

http://www.w3.org/2001/XMLSchema#string

Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML

about

P2860

P2860

Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932